These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7878563)

  • 1. Effect of exercise on the nasal transmucosal potential difference in patients with cystic fibrosis and normal subjects.
    Alsuwaidan S; Li Wan Po A; Morrison G; Redmond A; Dodge JA; McElnay J; Stewart E; Stanford CF
    Thorax; 1994 Dec; 49(12):1249-50. PubMed ID: 7878563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nasal transepithelial difference of potential in mucoviscidosis. Clinical application of the measurement].
    Maherzi A; Ategbo S; Pharaon I; Munck A; Cezard JP; Foucaud P; Navarro J
    Presse Med; 1995 Mar; 24(9):437-40. PubMed ID: 7746816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in exercise asthma.
    Schmitt L; Wiebel M; Frese F; Dehnert C; Zugck C; Bärtsch P; Mairbäurl H
    Eur Respir J; 2011 Feb; 37(2):342-8. PubMed ID: 20525718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transepithelial potential difference in cystic fibrosis.
    Hay JG; Geddes DM
    Thorax; 1985 Jul; 40(7):493-6. PubMed ID: 4035615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Status of determining the transepithelial potential difference (PD) of the respiratory epithelium in the diagnosis of mucoviscidosis].
    Unal-Maelger OH; Urbanek R
    Monatsschr Kinderheilkd; 1988 Feb; 136(2):76-80. PubMed ID: 2452977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.
    Knowles M; Gatzy J; Boucher R
    N Engl J Med; 1981 Dec; 305(25):1489-95. PubMed ID: 7300874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis.
    Rutland J; Cole PJ
    Thorax; 1981 Sep; 36(9):654-8. PubMed ID: 7314040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of nasal transepithelial potential difference: a diagnostic test for cystic fibrosis].
    Charfi MR; Matran R; Regnard J; Lockhart A
    Rev Pneumol Clin; 1996; 52(1):9-13. PubMed ID: 8731749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal potential difference: a clinical diagnostic test for cystic fibrosis.
    Alton EW; Currie D; Logan-Sinclair R; Warner JO; Hodson ME; Geddes DM
    Eur Respir J; 1990 Sep; 3(8):922-6. PubMed ID: 2292287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of nasal transepithelial potential difference (DDPTE) in cystic fibrosis. Analysis of a simplified measurement technique].
    Labbé A; Bellon G; Héraud MC; Arbre P; Goddon G; Alton E
    Arch Fr Pediatr; 1991 Nov; 48(9):617-20. PubMed ID: 1722389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.
    Middleton PG; Geddes DM; Alton EW
    Thorax; 1993 Aug; 48(8):812-6. PubMed ID: 8211871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of N-acetyl-cysteine (Mucosolvin) on the transmural potential difference of the mucosa in children.
    Ballke EH; Wiersbitzky S; Mahner B; König A
    Padiatr Grenzgeb; 1992; 31(2):97-101. PubMed ID: 1305285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nasal response to exercise in patients with cystic fibrosis.
    Strohl KP; Arnold JL; Decker MJ; Hoekje PL; Doershuk CF; Stern RC
    Rhinology; 1992 Dec; 30(4):241-8. PubMed ID: 1470825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
    Wilschanski M; Yahav Y; Yaacov Y; Blau H; Bentur L; Rivlin J; Aviram M; Bdolah-Abram T; Bebok Z; Shushi L; Kerem B; Kerem E
    N Engl J Med; 2003 Oct; 349(15):1433-41. PubMed ID: 14534336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of transepithelial potential difference measurements in cystic fibrosis.
    Sauder RA; Chesrown SE; Loughlin GM
    J Pediatr; 1987 Sep; 111(3):353-8. PubMed ID: 2442338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of nasal potential difference in adult cystic fibrosis, Young's syndrome, and bronchiectasis.
    Alton EW; Hay JG; Munro C; Geddes DM
    Thorax; 1987 Oct; 42(10):815-7. PubMed ID: 3424257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal potential measurements on the nasal floor and under the inferior turbinate: does it matter?
    Vermeulen F; Proesmans M; Feyaerts N; De Boeck K
    Pediatr Pulmonol; 2011 Feb; 46(2):145-52. PubMed ID: 20865746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of methacholine on nasal transmucosal potential difference in normal human subjects.
    Stewart EJ; Cinnamond MJ; Nicholls P; Stanford CF
    Rhinology; 1993 Jun; 31(2):77-9. PubMed ID: 8362174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects.
    Chetta A; Pisi G; Zanini A; Foresi A; Grzincich GL; Aiello M; Battistini A; Olivieri D
    Respir Med; 2001 Dec; 95(12):986-91. PubMed ID: 11778797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.